A genetic mutation found in two human patients with schizophrenia also increased schizophrenia-related behaviors in mice with ...

The mutation led to higher levels of glycine decarboxylase (GLDC), an enzyme that degrades glycine, reducing NMDA receptor activation. Mice with extra copies of the GLDC gene exhibited ...

University of Maribor, Faculty of Mechanical Engineering, Laboratory for Characterisation and Processing of Polymers, Smetanova ulica17, 2000 Maribor, Slovenia Members of the European Polysaccharide ...

Intra-Cellular Therapies' CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar de ...

The mutation increases levels of glycine decarboxylase, or GLDC, an enzyme responsible for regulating glycine in the brain. Glycine activates receptors for the neurotransmitter glutamate, called NDMA ...

Glycine activates receptors for the neurotransmitter glutamate, called NMDA receptors. "The genetics of schizophrenia is very complex, and it is rare that mutations found in patients can be linked ...

Glycine activates receptors for the neurotransmitter glutamate, called NDMA receptors. The genetics of schizophrenia is very complex, and it is rare that mutations found in patients can be linked ...

Process Research Department, Research & Development Division, Yuhan Corporation, Yong-in, Gyeonggi-do 17084, South Korea Functional Crystallization Center, Department of Chemical Engineering ...